Defective Drug and Pharmaceutical Product Liability Claims

## When Prescription Drugs Cause More Harm Than They Heal

Pharmaceutical companies have a legal duty to develop, test, and label their products safely. When a drug causes unexpected injury because of a design defect, manufacturing contamination, or inadequate warnings about known risks, injured patients have the right to pursue compensation through product liability law. These cases involve multiple legal theories, massive institutional defendants, and medical complexity that requires specialized legal expertise.

Mass tort pharmaceutical litigation has produced some of the largest personal injury settlements in US history — Purdue Pharma, Vioxx, and Talcum Powder cases collectively resulted in multi-billion-dollar settlements affecting hundreds of thousands of victims.

The Three Pathways to Pharmaceutical Product Liability

Each theory of drug liability requires different evidence and opens liability to different parties in the pharmaceutical supply chain.

**Defective design:** The drug's approved formulation carries risks that outweigh its benefits under the intended use conditions. This is difficult to prove because FDA approval creates a presumption of safety that must be overcome with scientific evidence.
**Manufacturing defect:** Contamination during production, improper dosage in specific lots, or packaging failures that compromise drug stability. FDA recalls often signal manufacturing defects that strengthen injury claims.
**Failure to warn:** The drug manufacturer knew about serious side effects and either omitted them from the prescribing information or minimized their severity, leaving prescribing physicians without the information needed to protect patients. This is the most common theory in pharmaceutical cases.

The learned intermediary doctrine — which holds that warning the prescribing physician is sufficient — is a common pharmaceutical defense. However, courts have increasingly rejected this defense in cases involving direct-to-consumer advertising, where drug companies bypass physicians and market directly to patients.

What a Pharmaceutical Injury Attorney Does for You

Drug injury cases require attorneys with both legal expertise and the scientific infrastructure to challenge pharmaceutical evidence.

Review internal company documents to find evidence that the manufacturer knew about risks before marketing
Retain board-certified physicians and pharmacologists as expert witnesses
Analyze whether the FDA approval process identified but minimized the risks involved
Research other injured patients who have reported the same adverse drug effects
Evaluate whether your case should be filed as an individual lawsuit or joined to an existing multidistrict litigation (MDL)
Calculate your full damages including future medical monitoring, ongoing treatment, and long-term disability

Pharmaceutical injury cases rarely resolve quickly. The litigation period can span years, and resolution often comes through global settlements affecting thousands of plaintiffs simultaneously. An attorney experienced in pharmaceutical litigation understands this timeline and protects your interests throughout the process.